Related Experiment Video
Updated: Aug 2, 2026

11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
Malignant cystosarcoma phyllodes with simultaneous carcinoma in the ipsilateral breast
Southern Medical Journal
|September 1, 1984
Summary
Malignant cystosarcoma phyllodes can coexist with breast cancer. Careful histologic examination is crucial for detecting simultaneous intraductal and infiltrating duct carcinoma in surrounding breast tissue.
Area of Science:
- Oncology
- Pathology
- Breast Cancer Research
Background:
- Cystosarcoma phyllodes is a rare breast tumor.
- Malignant variants require thorough evaluation.
- Coexisting malignancies can complicate diagnosis and treatment.
Observation:
- A 31-year-old Black woman presented with a malignant cystosarcoma phyllodes.
- The tumor involved surrounding breast tissue.
- Histologic examination revealed simultaneous intraductal and infiltrating duct carcinoma.
Findings:
- The case highlights the importance of meticulous histologic examination of the tissue adjacent to cystosarcoma phyllodes.
- Coexistent breast carcinoma was identified in this patient.
- This underscores the potential for multiple malignant pathologies within the same breast.
Implications:
- Early and accurate diagnosis of coexisting malignancies is vital for effective treatment planning.
- Pathologists must exercise vigilance when evaluating cystosarcoma phyllodes, considering the possibility of concurrent breast cancer.
- This case contributes to the understanding of complex breast tumor presentations and emphasizes diagnostic diligence.
More Related Videos
05:11Construction of An Orthotopic Xenograft Model of Non-Small Cell Lung Cancer Mimicking Disease Progression and Predicting Drug Activities
Published on: May 10, 2024
05:22Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma
Published on: February 13, 2026
Related Concept Videos
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...